Showing results (441-450 of 624) with videos related to
Sort By:
Pageof 63
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosisM P Martelli, M Martelli, E Pescarmona, et al.International Journal of Cancer|March 4, 1997
Transcription of latent and replicative Epstein-Barr-virus genes in bone-marrow and peripheral-blood mononuclear cells of healthy donorsR Gonnella, A Angeloni, A Calogero, et al.Bone Marrow Transplantation|August 1, 1997
Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trialR Zittoun, S Suciu, M Watson, et al.Haematologica|October 17, 2001
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot studyR Gastaldi, P Martino, G Gentile, et al.Blood|November 15, 1994
A controlled trial of recombinant human erythropoietin after bone marrow transplantationH Link, M A Boogaerts, A A Fauser, et al.British Journal of Haematology|June 1, 1988
Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effectJ F Apperley, F R Mauro, J M Goldman, et al.Bone Marrow Transplantation|January 2, 1997
Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study GroupH G Prentice, E Gluckman, R L Powles, et al.Leukemia|September 27, 2003
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent diseaseF Lo-Coco, A Romano, A Mengarelli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2016
Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with ChemoradiationYifan Wang, Hui Liu, Lixia Diao, et al.Cell Death & Disease|September 12, 2014
UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespibH Landmann, D A Proia, S He, et al.Pageof 63